In Veritas Medical Diagnostics, Inc.
IVMED · OTC
1/31/2008 | 10/31/2007 | 7/31/2007 | 4/30/2007 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.00 | -0.00 | 0.01 |
| FCF Yield | -147.05% | -43.91% | 17.29% | -13.26% |
| EV / EBITDA | -13.14 | -11.55 | -4.33 | -10.23 |
| Quality | ||||
| ROIC | 1.17% | 1.23% | 15.94% | 5.50% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.40 | 0.11 | -0.05 | 0.14 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -40.32% |
| Free Cash Flow Growth | -151.78% | -313.68% | 151.56% | 63.10% |
| Safety | ||||
| Net Debt / EBITDA | -12.62 | -10.89 | -4.01 | -8.58 |
| Interest Coverage | 1.27 | 0.00 | 0.00 | 1.75 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |